ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Microsoft India buys Rs 181.25 crore land parcel near Hyderabad from Natco Pharma
Microsoft has acquired a 121,000 sq yard land parcel near Hyderabad for ₹181.25 crore from Natco Pharma, adding to its growing land bank in India. This purchase likely signals further expansion of Microsoft's data center business in the region, compleme
Announcement as on 04 December 2024

Stocks in news: Waaree Renewable, Godrej Properties, Vedanta, PCBL, Natco Pharma
Moody's Ratings on Wednesday said it has upgraded the corporate family rating of Vedanta Resources Ltd (VRL), the parent of Vedanta, following its successful liability management exercises.
Announcement as on 28 November 2024

Natco Pharma Q2 Results: Net profit shoots up 83% to Rs 676 crore
Natco Pharma on Tuesday said its consolidated net profit jumped 83 per cent on-year to Rs 676 crore in the September 2024 quarter, aided by robust sales. The drug maker reported a net profit of Rs 369 crore in the July-September period of last fiscal.
Announcement as on 12 November 2024

Natco Pharma soars after Mylan settles Ozempic patent dispute
Natco Pharma rose 3.39% to Rs 1400.60 after the company announced a settlement in the U.S. patent litigation for generic Ozempic.
Announcement as on 07 October 2024

Natco Pharma stock rises 3% after subsidiary invests mn in biotech firm
Natco Pharma share price rose after the company on Wednesday announced that its wholly owned Canadian subsidiary, NATCO Pharma Inc, has made an investment of million in eGenesis
Announcement as on 04 September 2024

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 908.89
  • 12Day Average: 913.05
  • 20Day Average: 914.26
  • 50Day Average: 867.02
  • 100Day Average: 863.5
  • 150Day Average: 886.14
  • 200Day Average: 870.48

524816 Indicators & signals

Indicator MACD (12,26,9)

908.53, 898.37, 15.02
Indicator MACD is in positive zone

Indicator ADX (14)

9.82, 25.21, 20.7
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Tue Dec 2025 897.05 887.55 to 908.25 0.13% 0.91 times
29 Mon Dec 2025 895.90 894.20 to 911.30 -1.34% 0.5 times
26 Fri Dec 2025 908.10 905.70 to 920.00 -0.89% 0.83 times
24 Wed Dec 2025 916.25 911.50 to 926.70 -1.18% 1.04 times
23 Tue Dec 2025 927.15 922.50 to 950.40 0.38% 0.63 times
22 Mon Dec 2025 923.65 910.90 to 927.00 0.63% 1.09 times
19 Fri Dec 2025 917.90 913.10 to 943.00 0.33% 1.31 times
18 Thu Dec 2025 914.85 910.95 to 924.35 -0.83% 1 times
17 Wed Dec 2025 922.50 913.05 to 929.40 0.05% 1.15 times
16 Tue Dec 2025 922.05 904.45 to 928.00 1.87% 1.26 times
15 Mon Dec 2025 905.10 895.55 to 918.00 -0.11% 1.19 times
12 Fri Dec 2025 906.10 900.95 to 923.85 -1.4% 1.98 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top